Assignee
ESPERANCE PHARMACEUTICALS INC
US·5 granted patents·5 pending applications·8 citations·filing 2010–2021
Top patents by PatentIndex Score
10 records- 0182US10233214B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2016·Granted Mar 19, 2019·3 cites·28 claims
- 0282US9492563B2Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·5 cites·31 claims
- 0374US2022048951A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0473US2021324443A1METHODS FOR DIAGNOSING LHRH OR hCG/LH RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIASESPERANCE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0569US11066693B2Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and neoplasiasESPERANCE PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·18 claims
- 0664US10729740B2Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·20 claims
- 0763US2020353032A1Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0862US2019367558A1Antibody/drug conjugates and methods of useESPERANCE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0959US9255134B2Lytic domain fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2013·Granted Feb 9, 2016·0 cites·35 claims
- 1035US2011124564A1Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using sameESPERANCE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ESPERANCE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →